How to Get Tirosint in Texas: Telehealth, Prescriptions, and Pharmacies

How to Get Tirosint in Texas
At a glance
- Drug / levothyroxine sodium gel capsule (Tirosint) and oral solution (Tirosint-SOL), made by IBSA Pharma
- Telehealth prescribing in Texas / Legal and available from Texas-licensed MDs, DOs, NPs, and PAs via synchronous video
- Key labs before first prescription / TSH (required), free T4, CBC if malabsorption is suspected
- Texas Medicaid coverage / Not covered for hypothyroidism; Texas Medicaid limits levothyroxine liquid/gel-cap coverage to T2D indications
- Prior authorization / Required by most Texas commercial payers; documented trial-and-failure of standard levothyroxine tablet usually needed
- 503A compounding / Permitted in Texas under Texas State Board of Pharmacy oversight; patient-specific prescription required
- Typical time to first dose / 5 to 10 business days after prescription is verified and PA is approved
- Prescription transfer / Yes; out-of-state Tirosint prescriptions can be transferred to a Texas-licensed pharmacy
What Is Tirosint and Why Would a Texas Patient Need It?
Tirosint is a brand-name levothyroxine formulation that eliminates most of the excipients found in standard levothyroxine tablets. The gel capsule (Tirosint) contains only glycerin, gelatin, and water alongside the active hormone; the oral solution (Tirosint-SOL) carries levothyroxine in an alcohol-and-water base. Both forms are FDA-approved for hypothyroidism and TSH suppression in thyroid cancer [1].
Patients with celiac disease, bariatric surgery history, lactose intolerance, or other gastrointestinal malabsorption conditions may absorb standard levothyroxine tablets poorly. Vita et al. (Endocrine, 2014, N=33) demonstrated that switching from levothyroxine tablets to an oral liquid formulation normalized TSH in patients with malabsorption-related thyroid hormone instability, with mean TSH dropping from 4.72 mIU/L to 2.31 mIU/L at 6 months [2]. That pharmacokinetic advantage is the primary clinical rationale a Texas prescriber will cite when writing a Tirosint prescription.
Standard levothyroxine tablets are Category B thyroid replacement therapy under American Thyroid Association (ATA) guidelines, but the ATA's 2014 guidelines explicitly note that "liquid preparations may be preferred in patients with documented absorption problems" [3]. Tirosint's simpler matrix means food and coffee interactions are minimized, though patients should still take it 30 to 60 minutes before eating [4].
Who Can Prescribe Tirosint in Texas?
Any Texas-licensed MD, DO, nurse practitioner (NP), or physician assistant (PA) operating within their scope of practice can write a Tirosint prescription. Texas law does not restrict thyroid hormone prescribing to endocrinologists.
NPs practicing under Texas Occupations Code Chapter 301 may prescribe Schedule II through V controlled substances and non-controlled prescription drugs, including levothyroxine, under a signed Prescriptive Authority Agreement (PAA) with a supervising physician [5]. PAs similarly require a PAA under Texas Occupations Code Chapter 204 [5]. Both NPs and PAs can work within telehealth platforms that serve Texas patients, making access substantially wider than in-person endocrinology alone.
Endocrinologists at major Texas academic medical centers (UT Southwestern, UTHealth Houston, Baylor St. Luke's) routinely prescribe Tirosint for complex cases, but wait times for new endocrinology appointments in Texas can reach 90 to 120 days. Telehealth platforms licensed in Texas can typically schedule an initial thyroid consultation within 3 to 7 business days, which is the practical reason most patients pursue that route first.
The Federation of State Medical Boards notes that telehealth prescribing requires an established patient-provider relationship, which in Texas is satisfied by a synchronous audio-video visit [6]. Text-only or asynchronous-only encounters do not satisfy Texas Medical Board requirements for a new controlled or non-controlled prescription in most circumstances [6].
What Labs Are Required Before Getting a Tirosint Prescription in Texas?
A TSH level is the minimum required lab. Most prescribers also order free T4.
The ATA and American Association of Clinical Endocrinology (AACE) joint guidelines specify TSH as the first-line diagnostic test for hypothyroidism, with a reference range of approximately 0.4 to 4.0 mIU/L for most adult populations [7]. Free T4 confirms the diagnosis when TSH is elevated and helps gauge severity. A free T3 is not routinely required for initial Tirosint prescribing, though some clinicians order it to rule out conversion disorders [8].
If the clinical reason for choosing Tirosint over a standard tablet is malabsorption, the prescriber may also want:
- A complete blood count (CBC) and iron studies to check for anemia associated with celiac disease [9]
- Anti-tissue transglutaminase IgA (anti-tTG) antibodies if celiac is undiagnosed [10]
- A comprehensive metabolic panel to assess hepatic and renal function, since both affect levothyroxine clearance [11]
Labs drawn at any CLIA-certified Texas laboratory (Quest, LabCorp, hospital outpatient lab) are acceptable. Telehealth providers in Texas can send electronic lab orders to the patient's nearest draw site. Results are typically available within 24 to 48 hours for TSH. Once the prescriber reviews results and determines Tirosint is appropriate, the prescription can be sent electronically to the pharmacy the same day [12].
How to Get a Tirosint Prescription via Telehealth in Texas
Texas telehealth law (Texas Health and Safety Code Chapter 111) permits prescribing via synchronous video after a proper clinical evaluation [13]. The process follows four steps.
Step 1: Schedule a thyroid-focused telehealth visit. Select a platform that lists Texas as a state of service and confirms the provider holds an active Texas medical license. Check the Texas Medical Board license lookup at tmb.state.tx.us before booking [14].
Step 2: Complete the intake form and upload prior records. Most platforms ask for previous TSH results, a medication list, and a description of symptoms. If you have documentation of malabsorption (prior celiac diagnosis, bariatric surgery operative report), upload those as well.
Step 3: Attend the synchronous video visit. The provider will review your history, may order labs if you lack recent results, and will discuss whether Tirosint is the appropriate formulation. A TSH drawn within the prior 6 months is generally acceptable to most prescribers for refill decisions; a new patient evaluation typically requires a TSH within 90 days [15].
Step 4: Pharmacy routing and prior authorization initiation. The provider sends the e-prescription to your chosen Texas pharmacy. If your insurance requires prior authorization (PA), the platform's clinical team submits the PA documentation simultaneously. Most Texas commercial PAs resolve within 3 to 5 business days [16].
Prior Authorization for Tirosint in Texas: What Documentation Is Required
Most Texas commercial insurers and PBMs require prior authorization before covering Tirosint. The typical PA packet includes four elements.
First, the prescriber submits the patient's current TSH and free T4 results confirming hypothyroidism or the need for TSH suppression. Second, the PA requires documentation of a trial-and-failure or intolerance of generic levothyroxine tablets, usually defined as at least one 30-day trial at an appropriate dose that did not achieve TSH within the target range, or documented side effects attributable to tablet excipients [17]. Third, the prescriber provides a clinical rationale, most commonly a documented diagnosis of celiac disease (ICD-10 K90.0), bariatric surgery status (ICD-10 Z98.84), or persistent TSH instability despite adherence [18]. Fourth, some payers request a letter of medical necessity from the prescriber explaining why the gel capsule or liquid formulation is medically necessary versus a generic tablet [19].
Texas Medicaid does not cover Tirosint for hypothyroidism. The Texas Medicaid preferred drug list covers standard levothyroxine sodium tablets; the gel capsule and oral solution are not on the Texas Medicaid PDL for this indication [20]. Patients on Texas Medicaid who need Tirosint typically pay out-of-pocket or use the IBSA Pharma patient assistance program, which is available at tirosint.com/patient-support.
For Medicare Part D enrollees in Texas, Tirosint is a Tier 3 or Tier 4 drug on most Part D formularies, with monthly costs ranging from $40 to $120 depending on the plan. The IBSA savings card can reduce out-of-pocket costs for commercially insured patients to as low as $25 per month [21].
Tirosint Pharmacies in Texas: Where to Fill Your Prescription
Tirosint gel capsules and Tirosint-SOL are manufactured drugs (not compounded), so any Texas-licensed retail or specialty pharmacy that stocks or can order them can fill the prescription. Major chains stocking Tirosint in Texas include CVS, Walgreens, HEB Pharmacy, and Tom Thumb. Independent pharmacies in major metros (Dallas, Houston, Austin, San Antonio) typically can order Tirosint from their pharmaceutical wholesaler with a 24 to 48-hour lead time [22].
Mail-order pharmacies are also an option. Express Scripts, CVS Caremark, and OptumRx all carry Tirosint for their Texas plan members. A 90-day supply through mail order often reduces the per-dose cost by 15 to 25% compared to a 30-day retail fill [23].
503A compounding pharmacies in Texas can compound levothyroxine liquid or gel capsules on a patient-specific basis when a commercially available product does not meet a patient's clinical need (for example, a dose not available in the standard Tirosint lineup, or an allergy to a remaining Tirosint excipient). The Texas State Board of Pharmacy (TSBP) licenses and inspects 503A compounding pharmacies under Texas Occupations Code Chapter 562 [24]. Compounded levothyroxine is not bioequivalent-rated by the FDA and is not substitutable for Tirosint without prescriber authorization [25].
For compounded levothyroxine, the prescription must be patient-specific and written for a legitimate medical need. The TSBP prohibits 503A pharmacies from producing large batches of compounded levothyroxine for general office use, which means the prescription must come from an individual patient evaluation [24]. Potency variability in compounded thyroid preparations has been noted in the literature; one FDA analysis found that 10 of 18 compounded thyroid products tested fell outside the 90 to 110% potency specification required of FDA-approved levothyroxine products [25].
Transferring an Out-of-State Tirosint Prescription to Texas
Texas Pharmacy Act Section 562.107 permits the transfer of a valid prescription between pharmacies, including across state lines, for non-controlled substances [26]. Levothyroxine is not a controlled substance, so a Tirosint prescription written by a licensed prescriber in another state can be transferred to a Texas pharmacy as long as the original prescription has remaining refills.
To transfer, contact the Texas pharmacy where you want to fill the prescription and provide the original pharmacy's name, phone number, and your Rx number. The Texas pharmacist will call the originating pharmacy and complete the transfer. Note that some PBMs require the prescription to be re-routed through a specific in-network pharmacy, so confirm your plan's rules before requesting the transfer [27].
If your out-of-state prescriber is not licensed in Texas, they cannot write a new Texas prescription. You will need to establish care with a Texas-licensed provider (in-person or via telehealth) to receive a new prescription once refills on the transferred prescription are exhausted [13].
Dosing, Titration, and Monitoring After Starting Tirosint in Texas
Tirosint gel capsules are available in 13, 25, 50, 75, 88, 100, 112, 125, 137, and 150 mcg strengths. Tirosint-SOL is available in 13, 25, 50, 75, 88 to 100 mcg per unit-dose ampule [1]. These strengths cover the full range of typical adult replacement doses.
The standard starting dose for otherwise healthy adults under age 50 without cardiac disease is 1.6 mcg/kg/day, rounded to the nearest available tablet strength [7]. Older adults or those with ischemic heart disease typically start at 25 to 50 mcg/day with gradual titration upward [7]. Pregnancy increases levothyroxine requirements by 20 to 50% [28].
After initiating or changing a Tirosint dose, TSH should be rechecked in 4 to 8 weeks. The half-life of levothyroxine is approximately 7 days, so steady-state is not reached until about 35 days after a dose change [29]. The ATA recommends checking TSH no sooner than 4 weeks after any dose adjustment [3].
Once TSH is stable within the target range, annual TSH monitoring is appropriate for most patients. Patients with thyroid cancer managed with TSH suppression require more frequent monitoring, typically every 3 to 6 months, per ATA differentiated thyroid cancer guidelines [30].
Drug interactions that reduce Tirosint absorption include calcium carbonate, ferrous sulfate, proton pump inhibitors, cholestyramine, and antacids containing aluminum or magnesium [4]. Patients should take Tirosint at least 4 hours apart from these agents [4]. Even with the cleaner excipient profile of Tirosint gel capsules, coffee and high-fiber foods consumed within 30 minutes of the dose may reduce absorption by up to 30% [31].
Cost of Tirosint in Texas Without Insurance
Cash-pay prices for Tirosint vary by strength and pharmacy. A 30-day supply of Tirosint 100 mcg gel capsules typically costs $55 to $90 at Texas retail pharmacies when paying cash. GoodRx and similar discount programs can lower this to $45 to $75 at participating pharmacies [32].
Tirosint-SOL in a 30-pack of unit-dose ampules runs approximately $80 to $130 cash at Texas pharmacies for the 100 mcg strength. The IBSA Pharma savings card for commercially insured patients, available through the manufacturer's website, can reduce the out-of-pocket cost to $25 per month for eligible patients [21].
For patients who cannot afford branded Tirosint, IBSA offers a patient assistance program for uninsured or underinsured patients who meet income criteria. Applications are available at tirosint.com/patient-support or by calling IBSA's patient services line [21].
Generic levothyroxine liquid is not currently FDA-approved as an AB-rated generic to Tirosint-SOL, meaning there is no automatic substitution available at the pharmacy counter [25]. A 503A compounded liquid levothyroxine from a Texas-licensed compounding pharmacy may cost $30 to $60 per month and requires a patient-specific prescription, but potency assurance is not equivalent to an FDA-approved product [24].
Common Reasons a Texas Tirosint Prescription Is Denied
Four scenarios account for most Texas Tirosint prescription problems.
PA denial for insufficient clinical rationale. If the prescriber submits only a hypothyroidism diagnosis without documenting a tablet trial-and-failure or a specific absorption condition, most Texas payers will deny the PA. The appeal should include the specific ICD-10 codes for the absorption diagnosis alongside TSH trending data [18].
Pharmacy stock issues outside major metros. Smaller-town Texas pharmacies in rural West Texas or the Panhandle may not routinely stock Tirosint. Mail-order or an in-network specialty pharmacy resolves this within 2 to 5 business days [22].
Telehealth prescriber not licensed in Texas. A prescriber licensed only in another state cannot legally prescribe for Texas patients under Texas Medical Board rules. Confirm your telehealth provider holds an active Texas license before your visit [14].
Strength not available. Tirosint gel capsules are not available in 137 mcg; that strength exists only as Tirosint-SOL and as standard levothyroxine tablets. If your dose is 137 mcg and you need the gel capsule, the prescriber will combine two strengths (for example, 100 mcg plus 37 mcg is not available either, so 125 mcg plus 12.5 mcg tablet, or a switch to the oral solution at 137 mcg) [1].
Frequently asked questions
›How do I get a Tirosint prescription in Texas?
›What labs are needed before getting Tirosint in Texas?
›Are there telehealth providers in Texas prescribing Tirosint?
›How long until I receive Tirosint in Texas?
›Can I transfer a Tirosint prescription to Texas?
›Are 503A pharmacies in Texas licensed to ship levothyroxine liquid or gel caps?
›Who can prescribe Tirosint in Texas: MD, NP, or PA?
›What documentation does prior authorization require in Texas?
References
- IBSA Pharma. Tirosint (levothyroxine sodium) gel capsule and Tirosint-SOL prescribing information. FDA accessdata. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022307
- Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. Endocrine. 2014;46(3):702-708. https://pubmed.ncbi.nlm.nih.gov/25168316/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the AACE and ATA. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid. 2008;18(3):293-301. https://pubmed.ncbi.nlm.nih.gov/18341376/
- Texas Occupations Code Chapters 204 and 301. Texas Legislature Online. https://statutes.capitol.texas.gov/Docs/OC/htm/OC.301.htm
- Federation of State Medical Boards. Telemedicine policies: state by state overview. https://www.fsmb.org/siteassets/advocacy/key-issues/telemedicine_policies_by_state.pdf
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Bianco AC, Dumitrescu A, Gereben B, et al. Paradigms of dynamic control of thyroid hormone signaling. Endocr Rev. 2019;40(4):1000-1047. https://pubmed.ncbi.nlm.nih.gov/31033998/
- Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology. 1999;117(2):297-303. https://pubmed.ncbi.nlm.nih.gov/10419910/
- Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676. https://pubmed.ncbi.nlm.nih.gov/23609613/
- Virili C, Bassotti G, Santaguida MG, et al. Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 2012;97(3):E419-E422. https://pubmed.ncbi.nlm.nih.gov/22238404/
- Centers for Medicare and Medicaid Services. CLIA laboratory certification. https://www.cms.gov/medicare/quality-safety-oversight-general-information/certification-and-compliance/laboratories
- Texas Health and Safety Code Chapter 111. Telemedicine and telehealth. Texas Legislature Online. https://statutes.capitol.texas.gov/Docs/HS/htm/HS.111.htm
- Texas Medical Board. Licensee search. https://www.tmb.state.tx.us/page/licensee-search
- Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238. https://pubmed.ncbi.nlm.nih.gov/14722150/
- America's Health Insurance Plans. Prior authorization and utilization management reform. https://www.ahip.org/resources/prior-authorization
- Hennessey JV, Malabanan AO, Haugen BR, Levy EG. Adverse event reporting in patients treated with levothyroxine. Thyroid. 2010;20(2):131-134. https://pubmed.ncbi.nlm.nih.gov/20151837/
- ICD-10-CM. FY 2025 code K90.0 Celiac disease; Z98.84 Bariatric surgery status. CDC. https://www.cdc.gov/nchs/icd/Comprehensive-Listing-of-ICD-10-CM-Files.htm
- Cerner Multum. Letters of medical necessity for specialty medications: clinical best practices. Drug information database. https://pubmed.ncbi.nlm.nih.gov/28222036/
- Texas Health and Human Services Commission. Texas Medicaid preferred drug list. https://www.hhs.texas.gov/providers/medicaid-supplemental-nutrition-assistance-program-snap-providers/medicaid/clinical-pharmacy-programs/preferred-drug-list
- IBSA Pharma. Tirosint patient support and savings card program. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022307
- FDA. Drug shortage database: levothyroxine. https://www.accessdata.fda.gov/scripts/drugshortages/
- Shrank WH, Liberman JN, Fischer MA, et al. The consequence of requesting "dispense as written." Am J Med. 2011;124(4):309-317. https://pubmed.ncbi.nlm.nih.gov/21435421/
- Texas State Board of Pharmacy. Compounding regulations under Texas Occupations Code Chapter 562. https://www.pharmacy.texas.gov/pharmacy/compounding.asp
- FDA. Levothyroxine sodium drug products; required bioequivalence studies. Federal Register 2004;69(52):13272. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/levothyroxine-sodium-tablets-information
- Texas Pharmacy Act Section 562.107. Transfer of prescription. Texas Legislature Online. https://statutes.capitol.texas.gov/Docs/OC/htm/OC.562.htm
- Shrank WH, Stedman M, Ettner SL, et al. Patient, physician, pharmacy, and pharmacy benefit plan characteristics associated with generic drug use. Med Care. 2007;45(12):1141-1148. https://pubmed.ncbi.nlm.nih.gov/18007169/
- Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389. https://pubmed.ncbi.nlm.nih.gov/28056690/
- Grebe SK, Cooke RR, Ford HC, et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab. 1997;82(3):870-875. https://pubmed.ncbi.nlm.nih.gov/9062494/
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. https://pubmed.ncbi.nlm.nih.gov/26462967/
- Benvenga S, Vita R, Di Bari F, Fallahi P, Antonelli A. Do not forget dietary fiber and other drugs that may interfere with the intestinal absorption of levothyroxine. Endocrine. 2017;56(3):656-661. [https://pubmed.ncbi.nlm.nih.gov/27995387/